Acurx Pharmaceuticals Inc (ACXP)
2.17
+0.05
(+2.36%)
USD |
NASDAQ |
May 03, 16:00
2.17
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Free Cash Flow (Quarterly): -4.198M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.198M |
September 30, 2023 | -2.094M |
June 30, 2023 | -1.577M |
March 31, 2023 | -1.933M |
December 31, 2022 | -1.496M |
September 30, 2022 | -2.180M |
June 30, 2022 | -1.991M |
March 31, 2022 | -1.876M |
Date | Value |
---|---|
December 31, 2021 | -1.500M |
September 30, 2021 | -2.637M |
June 30, 2021 | -0.3298M |
March 31, 2021 | -0.5471M |
December 31, 2020 | -0.9598M |
September 30, 2020 | -0.7588M |
June 30, 2020 | -0.7338M |
March 31, 2020 | -0.8993M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.198M
Minimum
Dec 2023
-0.3298M
Maximum
Jun 2021
-1.607M
Average
-1.538M
Median
Free Cash Flow (Quarterly) Benchmarks
Tonix Pharmaceuticals Holding Corp | -22.78M |
Seelos Therapeutics Inc | -1.911M |
PetVivo Holdings Inc | -1.477M |
NovaBay Pharmaceuticals Inc | -0.316M |
Palatin Technologies Inc | -10.51M |